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Human skin is commonly colonized and infected by
Staphylococcus aureus. Exactly how these organ-
isms are sensed by keratinocytes has not been
clearly delineated. Using a combination of metabolic
and transcriptomic methodologies, we found that
S. aureus infection is sensed as a metabolic stress
by the hypoxic keratinocytes. This induces HIF1a
signaling, which promotes IL-1b production and
stimulates aerobic glycolysis to meet the metabolic
requirements of infection. We demonstrate that
staphylococci capable of glycolysis, including WT
and agr mutants, readily induce HIF1a responses.
In contrast, Dpyk glycolytic mutants fail to compete
with keratinocytes for their metabolic needs. Sup-
pression of glycolysis using 2-DG blocked keratino-
cyte production of IL-1b in vitro and significantly
exacerbated the S. aureus cutaneous infection in
a murine model. Our data suggest that S. aureus
impose ametabolic stress on keratinocytes that initi-
ates signaling necessary to promote both glycolysis
and the proinflammatory response to infection.
INTRODUCTION
Staphylococcus aureus are metabolically flexible pathogens that
are highly adapted to persist on and within human tissues, with
over 25% of individuals colonized with this organism (Jenkins
et al., 2015). Colonization includes superficial residence of these
bacteria on the skin as a component of themicrobiome (Oh et al.,
2016), intercalation within the layers of the epidermis (Nakatsuji
et al., 2013), and intracellular persistence within keratinocytes
(Soong et al., 2015). Skin and soft-tissue infections, as well as
systemic S. aureus infection, are usually caused by colonizing
strains, well documented in multiple whole-genome studies
(Fitzgerald, 2014). Although typically considered to be extracel-
lular pathogens, S. aureus can also persist within immune, endo-
thelial, and epithelial cells that can serve as foci of persistent or
recurrent infection. Often, these intracellular staphylococci har-
bor mutations in the agr locus affecting toxin expression (Shop-
sin et al., 2008; Smyth et al., 2012) or are small-colony variants2742 Cell Reports 18, 2742–2751, March 14, 2017 ª 2017 The Autho
This is an open access article under the CC BY-NC-ND license (http://(SCVs), typically metabolic auxotrophs (Kriegeskorte et al.,
2011), reflecting adaptation to the host (Golubchik et al., 2013)
(Proctor et al., 2006).
In response to S. aureus, keratinocytes initiate immune
signaling. Like immune cells, keratinocytes undergo many
fundamental changes following pathogen recognition. These
include increasing the surface display of receptors, upregulating
cytokine expression, and migrating to replace cells lost at the
site of infection—all functions that require energy. To meet the
increased metabolic demands of infection, many types of
immune cells shift from oxidative phosphorylation to aerobic
glycolysis, often referred to as metabolic reprogramming. This
switch to glycolysis is critical for the successful host response
to infection and has been documented in clinical settings using
patient-derived data (Shalova et al., 2015; O’Neill and Pearce,
2016). Keratinocytes express pattern recognition and NOD
(non-obese-diabetic)-like receptors, as well as the components
of the inflammasome, providing multiple mechanisms to initiate
proinflammatory signaling, but the relative importance of meta-
bolic responses to infection in the skin is not established.
An important trigger for the induction of glycolysis is tissue
hypoxia and the need to rapidly generate ATP in response to
perceived infection. The human epidermis, which is oxygenated
transdermally (O’Shaughnessy and Brown, 2015) (Ronquist
et al., 2003), presents a relatively hypoxic environment that
is further stressed by exposure to colonizing bacteria like
S. aureus. Local hypoxia in immune cells drives inflammatory
signaling through the activation of hypoxia-inducible factor 1a
(HIF1a) signaling. This increases glucose uptake and facilitates
glycolytic metabolism. HIF1a also stimulates the transcription
of pro-interleukin (IL)-1b, which contains an HRE (hypoxia-
response element) in its promoter and is an important compo-
nent of the inflammasome (Tannahill et al., 2013). As S. aureus
colonization of the skin itself generates localized hypoxia (Lone
et al., 2015), keratinocytes seem primed for the activation of
the glycolytic pathway, even without substantial tissue invasion.
Staphylococci express several genes activated under condi-
tions of hypoxia that facilitate skin and soft-tissue infections
(Wilde et al., 2015). These include the srrAB locus, a two-compo-
nent system that senses O2 (Pragman et al., 2007; Kinkel et al.,
2013), and rex, a redox sensor that regulates the expression of
genes necessary for metabolic activity in anaerobic conditions
(Pagels et al., 2010). Loci important in bacterial glycolysis, like
pyruvate kinase (pyk), have been found to mediate nitric oxider(s).
creativecommons.org/licenses/by-nc-nd/4.0/).
(NO) resistance required for virulence in skin and soft-tissue
infection (Vitko et al., 2015). Moreover, S. aureus express four
glucose transporters, suggesting that they are highly adapted
to support a high level of glycolytic flux under situations when
O2 is limited (Vitko et al., 2015).
AsS. aureus is amember of the commensal flora and themajor
cause of human skin infection, both the organism and the host
are highly adapted to each other. In the studies presented in
this report, we postulated that infection causes metabolic stress
sufficient to initiate HIF1a signaling and glycolysis, as the organ-
isms and skin compete for the limited oxygen and glucose. We
demonstrate not only that keratinocytes respond to the energy
demands of infection by activating HIF1a and glycolysis, but
also that S. aureus must generate ATP through glycolytic path-
ways in order to establish cutaneous infection.
RESULTS
S. aureus Impose Metabolic Stress upon Keratinocytes
Keratinocytes are poised to rapidly respond to the presence of
pathogenic bacteria. We postulated that S. aureus infection
forces keratinocytes to compete with the organisms for available
glucose and O2. Since staphylococci can reside within keratino-
cytes aswell as cause superficial infection, we compared several
mutant strains with differing levels of intracellular accumulation
and metabolic capabilities. These included wild-type (WT)
USA300 LAC MRSA, a frequent cause of human skin and soft-
tissue infection; an agr mutant, lacking toxin production and
capable of intracellular accumulation (Soong et al., 2015); a
Dpyk glycolytic mutant, lacking pyruvate kinase; and a DpckA
gluconeogenesis mutant, lacking phosphoenolpyruvate carbox-
ykinase and making it unable to regenerate glucose for energy
under stressed conditions (Vitko et al., 2015). Strains with muta-
tions in the srrA/B locus (White et al., 2014), a two-component
system important in O2 sensing and the coordinate response
to hypoxia (Kinkel et al., 2013; Yarwood et al., 2001), and rex, a
regulator of anaerobic metabolism and responses to NO, were
also studied (Pagels et al., 2010). Growth curves of the WT and
mutant strains under the experimental conditions used and in
anaerobiasis were analyzed to compare their relative abilities
to proliferate (Figure S1A). Screening studies that were per-
formed with transposon mutants are interpreted with caution,
and constructed deletions were used for most of the studies.
The metabolic response of keratinocytes under control condi-
tions or infected with various S. aureus strains, as well as the
bacterial strains themselves, was studied using a Seahorse
analyzer (Figures 1A–1D). This enabled us to compare infected
and uninfected keratinocytes by following O2 consumption rate
(OCR), which reflects oxidative phosphorylation and generation
of ATP through the tricarboxylic acid (TCA) cycle, and glycolytic
activity measured as extracellular acidification rate (ECAR),
which reflects lactate production as the endpoint of aerobic
glycolysis. The Seahorse assay involved following the addition
of glucose to stimulate metabolism, oligomycin to suppress
oxidative phosphorylation, and 2-DG (deoxyglucose) to shut
off glycolysis.
Following a 3-hr incubation withS. aureus (MOI, 20:1), the sub-
stantial oxidative activity of the keratinocytes infected with WTUSA300 S. aureus strain LAC was evident as a significantly
increased OCR was observed throughout the course of the
assay in comparison to the lower OCR associated with the unin-
fected keratinocyte control. The limited effect of oligomycin on
the infected keratinocytes, which inhibits oxidative phosphoryla-
tion, suggests that the metabolic activity is primarily due to
glycolysis. TheDpyk glycolyticmutant, in contrast to the comple-
mented strain, did not contribute to OCR or to the glycolytic ac-
tivity of the infected cultures, despite persisting in the media
used for the assays (Figures S1B and S1C). Assays measuring
the proton production rate (PPR), a different assessment of
glycolytic activity, confirmed the Dpyk phenotype (Figure S1D).
The DpckA mutant at baseline minimally increased the OCR
and was very close to the WT strain in stimulating glycolytic ac-
tivity in response to added glucose (Figure 1A). We similarly
compared strains with mutations affecting O2 sensing using
rex and srrA/B mutants (Figure 1B). The srrA/B and rex mutants
were comparable toWT strains in O2 consumption and exhibited
slightly less (srrA/B) or slightly more (rex) glycolytic activity than
the parental strain (Figure 1B). The metabolic impact of an agr
mutant lacking toxin expression, but capable of increased intra-
cellular accumulation, was similarly examined in keratinocytes
(Figure 1C). In response to glucose, the agr strain modestly
increased OCR and especially glycolytic activity in parallel with
the WT parent.
The overall contribution of bacterial metabolism to the net
changes in OCR and ECAR was negligible, indicating that the
changes in metabolism were driven primarily by the keratinocyte
response to infection (Figure 1D). Of note, heat-killed bacteria
failed to elicit metabolic changes in the keratinocytes, suggest-
ing that bacterial metabolism was affecting the keratinocytes,
not simply the presence of pathogen-associated molecular pat-
terns (PAMPs).
The metabolic response did not correlate with intracellular up-
take and persistence of the staphylococcal strains as assessed
by a gentamicin protection assay (Figure 1E). The agr mutant
accumulated to significantly greater amounts within the kerati-
nocytes than the other strains but did not differ significantly in
its induction of glycolytic activity in the infected cells (Figure 1C).
There was slightly greater intracellular persistence of the DpckA
mutant than theWT parental strain and significantly less intracel-
lular recovery of the Dpyk strain (Figure 1G). The rex and srrA/B
mutants were recovered from within the infected keratinocytes
to similar amounts at 24 hr, indicating that the relative amounts
of intracellular accumulation of the different mutants did not
correlate with their effects on the overall metabolic activity of
the infected keratinocytes. Rates of keratinocyte viability over
the course of the experiment did not differ substantially among
the various strains (Figures 1F and 1H).
Another way to assess the metabolic impact of S. aureus
infection on the keratinocytes is to follow the phosphorylation
of AMPK, the major cellular sensor of ATP (Mihaylova and
Shaw, 2011). In response to infection, there was induction of
phosphorylated AMPK (P-AMPK) (Figures 1I and 1J). Of note,
the Dpyk mutant, unable to initiate glycolysis, did not induce
P-AMPK. These results are consistent with the metabolic data,
indicating that the addition of S. aureus imposes a metabolic







Figure 1. S. aureus Infection Induces O2 Consumption and Glycolysis in Human Keratinocytes
(A–D) A Seahorse analyzer was used tomonitor themetabolic activity via oxygen consumption rate (OCR) and extracellular acidification rate (ECAR) of uninfected
primary keratinocytes (HEKn) and those exposed to S. aureusmetabolic (A), oxygen-sensing (B), and toxin-deficient (C) strains for 3 hr (MOI, 20:1) or to heat-killed
staphylococci. The metabolic activity of staphylococci at the same concentration alone was also measured (D). The additions of glucose, oligomycin, and 2-DG
(deoxyglucose) are indicated as vertical lines.
(E–H) In (E) and (G), intracellular uptake (2 hr) and persistence (24 hr) of S. aureus strains were quantified by gentamicin exclusion assay comparing WT (LAC
USA300), LAC agr null mutants, Tn mutants in the Je2 background, and Dpyk and DpckA deletion mutants in the LAC background. (F and H) Cell viability
assessed by trypan blue exclusion.
(I and J) Immunoblots showing phospho-AMPK of human keratinocytes exposed to PBS, WT, or agr S. aureus (I), as well as Dpyk and DpckA (J), after 4 or 24 hr.
Densitometry normalized to actin is shown for comparison.
Representative experiments from at least two independent assays are shown. For all graphs, each data point is the mean value ± SEM (n = 3). *p < 0.05;
****p < 0.0001, by one-way ANOVA. SeaHorse statistical significances are compared to PBS alone.S. aureus Induce HIF1a Signaling in Keratinocytes
Under hypoxic conditions, as often present in settings of infec-
tion, HIF1a signaling is induced to rapidly meet the metabolic
requirements for host defenses (Weichhart et al., 2015; O’Neill
et al., 2016; O’Neill and Pearce, 2016). Under normoxyic condi-
tions, mammalian target of rapamycin (mTOR) induces the
translation of HIF1a1 and HIF1a2, which are modified by prolyl
hydroxylases that subsequently interact with the ubiquitin E3
ligase of the von Hippel-Landau complex to target the proteins
for proteasomal degradation (Ward and Thompson, 2012). In
hypoxic conditions, prolyl hydroxylase activity is suppressed,
and HIF1a accumulates. HIF1a-dependent signaling promotes2744 Cell Reports 18, 2742–2751, March 14, 2017the expression of over 1,000 genes, many of which orchestrate
the uptake of glucose and expression of the components neces-
sary for glycolysis (Semenza, 2013), as well as transcription of
pro-IL-1b (Tannahill et al., 2013).
We analyzed RNA sequencing (RNA-seq) data using Ingenuity
Pathway Analysis (IPA) software (QIAGEN) comparing gene
expression in control and S. aureus USA300-infected human
keratinocytes in primary culture (HEKn cells) and in HaCaT cell
lines after 1 hr of exposure (MOI, 100:1). HIF1a and numerous
HIF1a-regulated genes that contribute to the transport and utili-
zation of glucose necessary for glycolysis were induced, and
several were confirmed by qRT-PCR (Figures 2A and 2B). There
Figure 2. Staphylococcal Induction of HIF1a in Keratinocytes
(A) An Ingenuity Pathway Analysis (IPA) was performed onRNA-seq data obtained fromboth human keratinocytes in primary culture (HEKn) andHaCaTs exposed
to S. aureus (WT) USA300 LAC for 1 hr (MOI, 100:1). Heatmap shows the relative activation of genes responsive to HIF1a.
(B and C) qRT-PCR (B) and ELISAs (C) were performed on keratinocytes in primary culture exposed to PBS or WT S. aureus, with and without a small-molecule
HIF1a inhibitor.
(D and E) qRT-PCR (D) and immunoblot (E) of HIF1a in primary keratinocytes after 24 hr of WT or agr infection. Densitometry normalized to actin is included for
comparison.
(F) Immunofluorescence staining of infected and control human skin grafts with a-keratin (red) and a-HIF1a (green) demonstrating co-localization (yellow) in the
infected grafts.
(G) H&E staining of sections from infected skin grafts. Arrow indicates areas of neovascularization.
Representative data from at least two independent experiments are shown. For all graphs, each data point is the mean value ± SEM (n = 4). *p < 0.05; **p < 0.01;
***p < 0.001; and ****p < 0.0001, by one-way ANOVA.was a 22-fold increase in HIF1a expression and similar levels of
induction of EGLN3, which catalyzes the formation of 4-hydroxyl
proline on HIF; PFK1 (phosphofrucktokinase 1), the enzyme
necessary to commit to glycolysis; and HK2 (hexokinase 2),
which phosphorylates glucose to initiate metabolism. The induc-
tion of known targets of HIF1a signaling was completely blocked
in cells treated with a HIF1a inhibitor, whereas tumor necrosis
factor (TNF) expression was not significantly altered (Figure 2C).
IL-1b, a component of the inflammasome and major cytokine in
skin defenses (Cho et al., 2012; Kitur et al., 2016), was also signif-
icantly upregulated. The agrmutant did not significantly increaseHIF1a transcription (Figure 2D), but both the WT and agrmutant
increased the amounts of HIF1a protein recovered in the infected
keratinocytes, consistent with the major regulation of HIF1a
abundance through stabilization that is dependent upon the ac-
tivity of the prolyl hydroxylases (Figure 2E). Activation of HIF1a
in vivo was confirmed in S. aureus-infected skin grafts main-
tained on severe combined immunodeficiency (SCID) mice
(Soong et al., 2015) (Figure 2F). Sections of the infected skin
grafts demonstrated neovascularization (indicated by an arrow),
consistent with the upregulation of VEGFA by HIF1a (Figure 2G).
These results confirm that staphylococcal infection contributesCell Reports 18, 2742–2751, March 14, 2017 2745
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Figure 3. HIF1a Induction of Cytokines
(A) qRT-PCR showing induction of HIF1a and HIF1a-dependent genes in keratinocytes exposed to PBS or WT USA300, Dpyk, and DpckA S. aureus for 24 hr.
(B) Immunoblot showing induction of HIF1a and P-S6 in primary keratinocytes exposed to PBS orWTUSA300S. aureus for 4 or 24 hr. Densitometry normalized to
actin is included for comparison.
(C) ELISA performed using supernatants from primary keratinocytes exposed to PBS or WT USA300 S. aureus background strains for 24 hr.
(D) qRT-PCR showing induction of HIF1a and HIF1a-dependent gene (EGLN3) in keratinocytes exposed to PBS and Je2 mutant rex or srrA/B S. aureus for 24 hr.
(E) Immunoblot showing induction of HIF1a and P-S6 in cells exposed to PBS or Je2 mutant rex or srrA/B for 4 and 24 hr. Densitometry normalized to actin is
included for comparison.
(F) ELISAs performed using supernatants from primary keratinocytes exposed to PBS or Je2 WT, rex, or srrA/B S. aureus for 24 hr.
(G) P-AKT was detected by immunoblot from primary keratinocytes infected with WT and agr S. aureus for 2 and 24 hr (bar indicates deletion of irrelevant lanes).
Densitometry normalized to actin is included for comparison.
(H) Sections of biopsied human skin grafts maintained on SCID mice stained for P-AKT. Arrows indicate P-AKT at basal and superficial layers of the epidermis.
(I) ELISA performed using supernatants from HaCaTs treated with inhibitors of AKT (triciribine) or TBK1/IKKε (BX795) with and without WT S. aureus for 24 hr.
Representative results from at least two independent experiments are shown. For all graphs, each data point is themean value ±SEM (n = 3). *p < 0.05; **p < 0.01;
***p < 0.001; and ****p < 0.0001, by one-way ANOVA.to keratinocyte hypoxia. The keratinocytes respond to infection
by upregulating the HIF1a cascade to increase glucose uptake
and promote glycolysis to generate energy.
S. aureus Glycolytic Activity Is Required to Activate
HIF1a Responses
Having observed that the S. aureus glycolytic mutant Dpyk did
not induce keratinocyte metabolic activity (Figure 1A), we pre-
dicted that only S. aureus strains able to participate in glycolysis
would induce HIF1a accumulation (Figure 3). At the level of tran-
scription, only the WT strain significantly induced HIF1a expres-
sion and that of the other HIF1a-associated genes (EGLN3, HK2,
and PFK1) (Figure 3A). More importantly, the post-translational
modification of HIF1a regulates the accumulation of the tran-
scription factor. We observed substantially more HIF1a protein2746 Cell Reports 18, 2742–2751, March 14, 2017accumulation as detected bywestern blot in keratinocyte lysates
from the WT and DpckA-infected keratinocytes relative to the
glycolytic mutant Dpyk (Figure 3B). We noted that the phosphor-
ylation of S6, a marker for proliferative activity, was suppressed
over the course of infection, but only by the bacterial strains
capable of glycolysis (Figure 3B). The induction of HIF1a also
correlated with the upregulation of the inflammasome-associ-
ated cytokines IL-1b and IL-18 (Figure 3C). The Dpyk mutant
failed to induce expression of these cytokines, but it did signifi-
cantly induce IL-17A, IL-12p40, IL-12p70, TNF, IL-8, and inter-
feron g (IFNg) which are not HIF1a dependent (Figure 3C).
The O2 and redox sensing mutants, srrA/B and rex, were
somewhat impaired in their induction of HIF1a and EGLN3
gene expression (Figure 3D). However, these mutants that are
capable of glycolysis stimulated HIF1a protein accumulation to
levels similar to those achieved by infection with the WT strain
(Figure 3E). Neither the rex nor the srrA/B mutants were signifi-
cantly impaired in their induction of IL-1b and IL-18, in compar-
ison to the WT strain (Figure 3F). Thus, once adapted to the
ambient conditions, the bacteria also activate similar keratino-
cyte responses.
Our data suggest that S. aureus stimulate both glycolysis
and IL-1b production through the accumulation of HIF1a as a
consequence of local hypoxia. However, as noted in Figure 3B,
S. aureus also appeared to be stimulating the transcription of
HIF1a. Several upstream signaling pathways converge at the
central regulators of metabolism mTOR/AKT, which increase
HIF1a translation by 4E-BP1 (Weichhart et al., 2015). The induc-
tion of P-AKT/mTOR could occur via a staphylococcal activation
of a G protein-coupled receptor (GPCR) at the cell surface,
through phosphatidylinositol 3-kinase (PI3K) or through Toll-
like receptor (TLR) signaling via TBK1/IKKε (Everts et al., 2014).
We found that both WT and agr mutant S. aureus stimulate
P-AKT (Figure 3G) in vitro and in infected human skin grafts
maintained on SCID mice (Figure 3H). However, treatment of
keratinocytes with wortmannin (10 mM) or rapamycin (10 mM)
to inhibit PI3K andmTOR, respectively, had no significant effects
on cytokine production, despite potently suppressing P-AMPK
(Figure S2). Similarly, inhibition of TBK1 and AKT with BX795
or triciribine, respectively, increased keratinocyte IL-1b expres-
sion induced by WT S. aureus (Figure 3I). These observations
suggest that the major impact of S. aureus on the keratinocytes
ismetabolic and that TBK1 or GPCR signaling is not as important
in the induction of keratinocyte signaling as themetabolic impact
of infection.
Glycolytic Metabolism Is a Key Component of Host
Defense to Cutaneous Infection
To determine the in vivo significance of keratinocyte glycolysis in
S. aureus infection, we treated mice with 2-DG to inhibit glycol-
ysis 1 day prior to and during the course infection with WT or the
Dpyk mutant. Although the 2-DG-treated mice had equivalent
bacterial loads to the PBS-treated controls in the 5-mm punch
biopsy (Figure 4A), the extent of the associated dermonecrosis
was significantly greater in the 2-DG-treated mice, reflecting
an overall greater bacterial load (Figures 4B and 4D). Bacterial
accumulation was dependent on the glycolytic capabilities of
S. aureus, as there was a significantly lower bacterial burden in
Dpyk-infected mice (Figure 4C) and no obvious dermonecrotic
lesions (Figure 4D). Over the course of infection, 2-DG-treated
mice had significantly less TNF produced after 1 day and less
IL-1b after 5 days, while the Dpyk failed to elicit any proinflam-
matory response (Figure 4E). The histopathological changes
observed in the 2-DG-treated mice included substantially
increased vascularity and adiposity (a marker of inflammation)
in the 2-DG-treated mice (Figure 4F). Although there were no
differences in neutrophil or natural killer (NK) cell recruitment
in response to 2-DG treatment, there were significantly more
interstitial macrophages in fluorescence-activated cell sorting
(FACS) analysis of the infected skin lesions (Figure 4G).
In vitro studies with 2-DG-treated keratinocytes demonstrated
significantly decreased induction of IL-1b as compared to PBS-
treated controls (Figure 4H). Under control conditions, there wasincreased cytotoxicity associated with 2-DG treatment that was
further increased by infection with organisms capable of glycol-
ysis, including the complemented but not the Dpyk mutant
(Figure 4I). These studies further indicate a central role for the
induction of keratinocyte glycolysis as part of an effective host
response to staphylococcal skin infection as well as demon-
strating the importance of staphylococcal glycolytic activity in
establishing infection.
DISCUSSION
Keratinocytes have amajor role in host defense, providing both a
physical and immunological barrier against infection. The factors
that initiate keratinocyte signaling in the presence of a substan-
tial skin microbiome consisting of both commensal and patho-
genic flora are not completely understood. Our studies suggest
that S. aureus infection induces considerable metabolic stress
in keratinocytes as directly measured by changes in OCR and in-
duction of glycolysis in infected cells. Bacterial competition for
glucose and O2 stimulates the keratinocyte response, and bac-
teria unable to participate in glycolysis fail to activate the skin
cells. The limited availability of O2 in the human epidermis in-
creases susceptibility to metabolic stress and reliance upon
glycolysis to rapidly generate energy in response to perceived
infection (O’Shaughnessy and Brown, 2015).
The keratinocyte response to S. aureus is mediated by the
induction of HIF1a signaling. Numerous studies have identified
HIF1a as a major transcription factor activated in the setting
of infection to rapidly meet increased metabolic requirements
(Ward and Thompson, 2012). This is especially relevant in the
setting of the relative hypoxia of human skin. Staphylococcal in-
duction of HIF1a directly correlated with the organism’s ability to
use glycolysis to generate ATP, and only the glycolytic mutant
Dpyk that did not impose a metabolic stress upon the keratino-
cytes completely failed to stimulate keratinocyte metabolism or
HIF1a activity.WT and toxin-deficient agrmutant strains, despite
substantially different abilities to persist within keratinocytes,
both induced HIF1a accumulation. A growing literature docu-
ments the central role of HIF1a in coordinating metabolic and
inflammatory responses, as well as participating in epithelial
barrier function in the setting of infection (Rezvani et al., 2011).
HIF1a has been shown to be induced and stabilized in the setting
of low O2 as present in the skin (Boutin et al., 2008; Ronquist
et al., 2003), contributing to local production of antimicrobial
peptides (Peyssonnaux et al., 2008) and supporting barrier func-
tion (Wong et al., 2015). Our studies suggest amore fundamental
role for HIF1a in coordinating the metabolic and immune func-
tions of the skin in the setting of acute infection.
A major consequence of HIF1a signaling is the generation of
proinflammatory cytokines—particularly, mature IL-1b and IL-
18 associated with the inflammasome. The presence of staphy-
lococcal PAMPS that are known to be immunostimulatory was
not sufficient to induce an IL-1b response in the absence of
glycolytic activity. Numerous studies have identified IL-1b as be-
ing especially important in the effective clearance of S. aureus
skin infection (Cho et al., 2012; Soong et al., 2012). Various toxins
expressed by the USA300 MRSA strains used in these experi-
ments, including Hla, LukAB, and PVL, have each been shownCell Reports 18, 2742–2751, March 14, 2017 2747
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Figure 4. Participation of Glycolysis in Host Response to S. aureus Skin Infection
(A and B) Bacterial load after 5 days (A) and dermonecrosis (B) in mice treated with PBS or 2-DG (n = 14).
(C) Bacterial load after 5 days in mice infected with WT or Dpyk S. aureus (n = 7 and 9).
(D) Images of mouse lesions after 5 days of WT or Dpyk infection with and without 2-DG.
(E) Cytokine measurements by ELISA from skin biopsies of the infected sites after 1 day and 5 days (n = 5).
(F) H&E staining of skin sections taken fromWT infected mice with and without 2-DG treatment. Insets indicate areas of adipogenesis, and arrow indicates blood
vessels.
(G) Cell populations recruited in response to cutaneous WT infection in PBS- and 2-DG-treated mice after 5 days of exposure to WT S. aureus.
(H and I) ELISA (H) and lactate dehydrogenase (LDH) (I) assays performed on supernatants obtained from primary keratinocytes treated with 2-DG and WT,
mutant, or heat-killed S. aureus strains for 24 hr (n = 4).
Representative results from at least two independent experiments are shown. For all graphs, each data point is the mean value ± SEM. *p < 0.05; **p < 0.01;
***p < 0.001; and ****p < 0.0001, by one-way ANOVA.to be capable of stimulating the NLRP3 inflammasome and IL-1b
(Craven et al., 2009; Holzinger et al., 2012; Melehani et al., 2015).
However, in the presence of an HIF1a inhibitor, the IL-1b
response was virtually eliminated. These observations indicate
that the induction of HIF1a and the generation of pro-IL-1b are
likely to be critical steps to prime the keratinocyte for subsequent
activation of the inflammasome by S. aureus toxins. The stimula-
tion of glycolysis and IL-1b signaling appear to be generic re-
sponses of keratinocytes to S. aureus and not solely dependent
upon the expression of specific virulence factors or toxins.
We observed that staphylococcal genes involved in sensing
hypoxia (srrA/B), but not oxidative or nitrosative stress (rex),
only modestly affected the ability of S. aureus to stimulate a ker-2748 Cell Reports 18, 2742–2751, March 14, 2017atinocyte HIF1a response. These mutants confer a somewhat
diminished metabolic stress upon the keratinocytes, but once
adapted to the milieu, they are capable of using glycolysis to
generate energy. Previous studies indicated an impaired ability
of the srrA/B mutants to cause osteomyelitis, which may be
due to limited ability to initiate glycolysis or increased suscepti-
bility to the reactive oxygen species (ROS) generated by re-
cruited immune cells (Wilde et al., 2015). A more conclusive
phenotype has been ascribed to the Dpyk glycolytic mutant,
which is significantly attenuated in models of skin and soft-tissue
infection (Vitko et al., 2016), as was a S. aureusmutant lacking all
four glucose transporters similarly interfering with glycolytic ac-
tivity (Vitko et al., 2015). Although the Dpyk mutant stimulated
an IL-17A response, it did not activate metabolic stress or
stimulate HIF1a accumulation, nor did it suppress proliferative
signaling mediated by phosphorylation of S6.
The systemic inhibition of glycolysis with 2-DG resulted in
significantly larger S. aureus-induced skin lesions with delayed
healing and decreased IL-1b production, which is a key factor
in the resolution of skin infection (Cho et al., 2012). The increased
abundance of dermal adipocytes in the 2-DG-treated mice is
consistent with recent studies documenting the importance of
adipocytes in protection from S. aureus infection (Zhang et al.,
2015). In contrast, 2-DG was found to have protective effects
in a model of systemic L. monocytogenes infection. Thus, there
are clearly important differences in the metabolic responses to
specific pathogens and sites of infection (Wang et al., 2016).
There is a growing literature linking the induction of specific
metabolic pathways and immune signaling in macrophages,
dendritic cells, and the many different types of T cells. For
keratinocytes, this association between metabolic activity and
keratinocyte function in host defense is especially important.
The relative hypoxia of the skin lowers their threshold for activa-
tion of HIF1a and glycolysis and provides a commonmechanism
to provide both the metabolic and proinflammatory response to
cutaneous colonization/infection. Overall, our findings confirm
the clinical importance of glycolysis in promoting host de-
fenses—specifically, in the context of S. aureus skin infection.
EXPERIMENTAL PROCEDURES
Bacterial Strains and Growth Curves
The USA300 LAC strain and an agr deletion mutant have been previously
described (Soong et al., 2015). The Dpyk and DpckA mutants and a comple-
mented Dpyk mutant also in the LAC background were compared to their
USA300 LAC parent (Vitko et al., 2015). Tn mutants from the Je2 NARSA
(Network on Antimicrobial Resistance in Staphylococcus aureus) library were
used for screening studies, and the rex and the srrA and srrB mutants were
compared with the Je2 parental control; the srrA/B null mutant in the LAC
background and parent strains were obtained from W. Nauseef (White et al.,
2014). For growth curves, starter cultures were grown overnight in Luria broth
(LB) media and then diluted to an optical density at 600 nm (OD600) of 0.1 in LB,
DMEM, or Dermalife media with and without 0.5% sodium pyruvate (n = 4).
Cultures were grown in either an anaerobic chamber or a standard 37C incu-
bator, and the OD600 was taken at 30-min intervals in a 96-well plate using an
automated Tecan reader.
Tissue Culture, Infections, and Cytokine Panels
The human HaCaT keratinocyte cell line was grown in DMEM with 10% fetal
bovine serum (FBS) and 1%penicillin/streptomycin. HEKn cells were obtained
from GIBCO and grown in Dermalife (Lifeline Cell Technologies) with 1% FBS
and 1% penicillin/streptomycin. Primary cells were only used up to passage 7.
For infections, media were changed to DMEM or Dermalife without penicillin/
streptomycin the night before infection. Bacteria were grown in LB to an OD600
of 1 and added to cell media 1 hr after fibronectin was added at 10 mg/mL. In-
hibitors rapamycin (10 mM), wortmannin (10 mM), compound C (20 mM), Hif1a
inhibitor (10 mM), 2-DG (100 mM), triciribine (20 mM), and BX795 (5 mM) were
added 1 hr before infection. For gentamicin exclusion assays, media was
changed to DMEM or Dermalife with 500 mg/mL gentamicin 2 hr after infection.
Cells were lifted from the tissue culture plate with Tryple Express (Life Technol-
ogies), serially diluted, and plated on LB agar 2 and 24 hr after gentamicin was
added. Cellular viability was assessed by trypan blue staining and measured
using a ‘‘Countess’’ Illuminator. For cytokine panels, 500 mg/mL gentamicin
was added to the infected keratinocytes after 2 hr of incubation, and superna-
tants were collected at 24 hr and sent to Eve Technologies for cytokine anal-
ysis, or analysis was performed using commercially available kits (Biolegend).SCID:hu Mice and Confocal Staining
SCID:hu mouse graft methods were performed as previously described
(Soong et al., 2015). In brief, NOD-scid IL2Rg (NSG) mice (the Jackson
Laboratory) were grafted with human neonatal foreskin, per Columbia Uni-
versity Institutional Review Board (IRB) protocol AAAN6306. After matura-
tion (3–6 weeks), a 10-mL aliquot of 108 colony-forming units (CFUs) of
USA300 or PBS were applied dropwise. Skin grafts were excised after
72 hr. Skin biopsies were fixed in 4% paraformaldehyde for 24 hr and
then 70% ethanol for 24 hr. Sections were then preserved in paraffin blocks
and mounted on immune slides in 6-mm sections. Sections were deparaffi-
nized using SafeClear xylene substitute and ethanol and then microwaved in
sodium citrate buffer (sodium citrate, 10 mM; 0.05% Tween 20, pH 6) for
three 5-min rounds for antigen presentation. Slides were washed in Tween
20 0.5% for 10 min to permeabilize the sections and then washed in Triton
X-100. Sections were then blocked in 10% normal donkey serum in 1% BSA
for 1 hr, and primary antibodies were applied overnight in 1% BSA at 4C.
Slides were washed in Triton X-100, and secondary antibodies (Molecular
Probes Alexafluores) were applied in 1% BSA for 1 hr. Coverslips were
then mounted using Vectashield. Controls were performed using only sec-
ondary antibody.
Western Blots and Antibodies
Cell lysates were frozen in RIPA + HALT. Blots were run using Bolt mini gels
(Lifetech) and transferred using the iBlot machine (Lifetech). Antibodies for
Hif1a (Cayman Chemical), P-S6 (Cell Signaling), S6 (Cell Signaling), P-AKT
(Cell Signaling), AKT (Cell Signaling), P-AMPK (Cell Signaling), AMPK (Cell
Signaling), and b-actin (Santa Cruz Biotechnology) were used.
RNA Analysis and siRNA
ON-TARGETplus SMARTpool Human Hif1a siRNA and ON-TARGETplus non-
targeting scrambled control pool siRNAs were purchased from Dharmacon
and transfected into HEKn cells using Lipofectamine RNAiMAX (Life Technol-
ogies) per the manufacturer’s instructions. Cell lysates were saved in TRK
Lysis Buffer, and RNA was isolated using the EZNA RNA Kit (Omega Biotech).
cDNA was synthesized from RNA using the High Capacity cDNA Reverse
Transcription Kit (Applied Biosystems) and analyzed using the StepOne
qPCR machine and Power SYBR Green PCR Master Mix (Applied Bio-
systems). The following target genes and primers are listed as follows: Hif1a
(forward: CCCTAACGTGTTATCTGTCGCT; reverse: AGTAGCTGCATGATCG
TCTGG); EGLN3 (forward: GCGTCTCCAAGCGACAC; reverse: TTTCCCGGA
TAGCAAGCCAC); HK2 (forward: CAAAGTGACAGTGGGTGTGG; reverse:
GCCAGGTCCTTCACTGTCTC); PFK1 (forward: AAGCATCATCGAAACGC
TCTC; reverse: GGTGCCCGTGTCTTCTTTGT); and b-actin (forward: AGAGC
TACGAGCTGCCTGAC; reverse: AGCACTGTGTTGGCGTACAG).
Lactate Dehydrogenase Assay
Lactate dehydrogenase assay was performed as per manufacturer’s instruc-
tions (Roche) and as previously described (Kitur et al., 2016).
Seahorse Glycolysis Stress Test
HaCaTs or HEKn cells were infected at 60,000 cells per well according to
Seahorse protocol. Fn (fibronectin) was added 1 hr before infection, and bac-
teria were added (MOI, 20:1) for 3 hr. Seahorse analysis was performed ac-
cording to the XF Glycolysis Stress Test Kit User Guide (wells were washed
in XF Base Medium + 200 mM L-glutamine, incubated at 37C without CO2
for 45 min, then placed in the Seahorse analyzer). The analysis consisted
of a 20-min observation period followed by the addition of glucose to stim-
ulate glycolysis, the addition of oligomycin to suppress oxidative phosphor-
ylation, and the addition of 2-DG to block glycolysis, each at 20-min
intervals. The metabolic activity of the bacteria was determined by adding
the same amount of bacteria in other Seahorse assays without any
HaCaTs or HEKn cells.
RNA-Seq Analysis
HaCaTs and HEKn cells were infected with WT USA300 S. aureus (MOI, 100:1)
for 1 hr before cell lysates were prepared. Poly(A) pull-downwas used to enrich
mRNAs from total RNA samples (200 ng–1 mg per sample, RIN > 8 required)Cell Reports 18, 2742–2751, March 14, 2017 2749
and to proceed to library preparation by using the Illumina TruSeq RNA Prep
Kit. Libraries were then sequenced using Illumina HiSeq 2500 at the Columbia
Genome Center. The samples were multiplexed in each lane, which yields the
targeted number of single-end/paired-end 100-bp reads for each sample as a
fraction of 180 million reads for the whole lane.
Real-Time Analysis (RTA; Illumina) was used for base calling, and
bcl2fastq (version 1.8.4; Illumina) was used for converting BCL to fastq
format, coupled with adaptor trimming. The reads were mapped to a
reference genome (human: NCBI/build37.2; mouse: UCSC [University of
California, Santa Cruz]/mm9) using TopHat (Trapnell et al., 2009), with four
mismatches (–read-mismatches = 4) and ten maximum multiple hits
(–max-multihits = 10). To tackle the mapping issue of reads that are from
exon-exon junctions, TopHat infers novel exon-exon junctions ab initio
and combines them with junctions from known mRNA sequences (refgenes)
as the reference annotation. The relative abundance (a.k.a. expression level)
of genes and splice isoforms was estimated using Cufflinks (Trapnell et al.,
2010) with default settings. Differentially expressed genes were tested under
various conditions using DESeq (Anders and Huber, 2010). It is an R pack-
age based on a negative binomial distribution that models the number reads
from RNA-seq experiments and tests for differential expression. Expression
values were analyzed using IPA software, as previously described (Ahn
et al., 2016).
Model of Skin Infection
Six- to 8-week-old sex-matched C57BL/6J mice (the Jackson Laboratory)
were inoculated subcutaneously on the back with 2 3 106 CFUs of WT
USA300 or the Dpyk mutant in 100 mL PBS or PBS alone as a control, and le-
sionsweremeasured daily and followed for 5 days as previously described (Ki-
tur et al., 2016). 2-DG (1 g/kg) treatment was initiated the day prior to infection
and followed over the course of the experiment. Punch biopsies (5 mm) were
taken at the borders of the infected lesion and normal-appearing skin. The bio-
psied tissue was homogenized through 40-mm filters prior to the hypotonic
lysis of red blood cells. Recovered bacteria were enumerated. Keratinocytes
and immune cells were spun down, and a homogenate was used for cytokine
ELISA. Immune cells were stained with fluorescently conjugated markers and
analyzed by FACS, as described previously (Ahn et al., 2016). Skin specimens
were also fixed in 70% ethanol for histology, performed by the Columbia
University Medical Center. Trichrome staining was done, and images were
examined on a Zeiss Axiocm MRc. The protocol was approved by the Institu-
tional Animal Care and Use Committee (IACUC) protocol (AAAR0406 and
AAAR5412).
Ethics Statement
Animal experiments were carried out in strict accordance with the recommen-
dations in the Guide for the Care and Use of Laboratory Animals of the NIH,
the Animal Welfare Act, and U.S. federal law. The Institutional Animal Care
and Use Committee of Columbia University approved the protocol (AC-
AAAH2350 and AC-AAAG7408).
Statistical Analysis
Multiple comparisons were analyzed using one-way or two-way ANOVA with
Dunnett’s posttest. Normal distributions were analyzed by Student’s t test.
Mouse samples were compared using the nonparametric Mann-Whitney
test. RNA-seq analysis was conducted using the Benjamini-Hochbergmultiple
comparison test. Statistical analyses were performed with GraphPad Prism
software, with significance defined as p < 0.05.
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